Gen. Mgr., Precision Oncology
Tue, Feb 21, 2023
Feb 21
exercised or converted securities in EXAS
1,729 shares @ $0.00
Increased holdings by +37.60%
Option Exercise
Sale tied to a same-time option exercise
EXASEXACT SCIENCES CORP
Health CareHealth Care Services